A combination vinorelbine-estramustine in patients with hormone refractory prostate cancer

被引：0
|
作者：
Butera, A. [1 ]
Tornabene, P. [1 ]
机构：
[1] UO Oncol Med AOS Giovanni Dio Agrigento, Vicenza, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate
    Mackler, Niklas J.
    Dunn, Rodney L.
    Hellerstedt, Beth
    Cooney, Kathleen A.
    Fardig, Judith
    Olson, Karin
    Pienta, Kenneth J.
    Smith, David C.
    CANCER, 2006, 106 (12) : 2617 - 2623
  • [2] Vinorelbine (VNB) and estramustine (EMP) in hormone-refractory prostate cancer (HRPC).
    Ferraù, F
    Morgia, G
    Priolo, D
    Vitale, F
    Parisi, A
    Mattina, M
    Calì, S
    ANNALS OF ONCOLOGY, 2000, 11 : 77 - 77
  • [3] Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients
    Takenaka, Atsushi
    Yamada, Yuji
    Kurahashi, Toshifumi
    Soga, Hideo
    Miyake, Hideaki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (01) : 106 - 109
  • [4] Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination
    Athanasiadis, A
    Tsavdaridis, D
    Rigatos, SK
    Athanasiadis, I
    Pergantas, N
    Stathopoulos, GP
    ANTICANCER RESEARCH, 2003, 23 (3C) : 3085 - 3088
  • [5] Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients
    Carles, Joan
    Domenech, Montserrat
    Gelabert-Mas, Antonio
    Nogue, Miquel
    Tabernero, Josep M.
    Arcusa, Angeles
    Guasch, Inmaculada
    Miguel, Ana
    Ballesteros, Juan J.
    Fabregat, Xavier
    Acta Oncologica, 37 (02): : 187 - 191
  • [6] Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer
    Urakami, S
    Igawa, M
    Kikuno, N
    Yoshino, T
    Kishi, H
    Shigeno, K
    Shiina, H
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2444 - 2450
  • [7] Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer
    Safarinejad, MR
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (02) : 93 - 101
  • [8] Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients
    Carles, J
    Domenech, M
    Gelabert-Mas, A
    Nogue, M
    Tabernero, JM
    Arcusa, A
    Guasch, I
    Miguel, A
    Ballesteros, JJ
    Fabregat, X
    ACTA ONCOLOGICA, 1998, 37 (02) : 187 - 191
  • [9] Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer
    Nakabayashi, Mari
    Ling, Jonathan
    Xie, Wanling
    Regan, Meredith M.
    Oh, William K.
    CANCER JOURNAL, 2007, 13 (02): : 125 - 129
  • [10] Vinorelbine and prednisone are efficacy combination in hormone refractory metastatic prostate older cancer patients
    Tralongo, P
    Di Mari, A
    Conti, G
    Aiello, R
    Bollina, R
    Beretta, G
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 373 - 373
12345